Salarius Pharmaceuticals, LLC
Decoy Therapeutics develops peptide antivirals designed to target multiple respiratory viruses using its IMP(3)ACT platform, which combines AI-assisted design and rapid synthesis.
SCHEDULE 13G/ANov 16Latest SEC filing
Oct 7Latest story
October 2026
September 2026
July 2026
June 2026